Advancing Rare Disease Care: FSGS Market Poised for Steady Growth...

добавлена новая статья Другое

2026-04-24 06:08:29 -

Advancing Rare Disease Care: FSGS Market Poised for Steady Growth Toward $956.2 Million by 2031

The global industry was valued at US$ 538.5 Mn in 2022 and is estimated to advance at a CAGR of 6.5% from 2023 to 2031, reaching US$ 956.2 Mn by the end of 2031. The focal segmental glomerulosclerosis (FSGS) market is gaining momentum as increasing awareness, improved diagnostic capabilities, and advancements in targeted therapies drive growth. FSGS, a rare kidney disorder characterized by...

0 Комментарии 0 Поделились 18 Просмотры